Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hepatitis × Methylprednisolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 5 Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 4 Recurrence 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Multiple Myeloma 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large-Cell, Anaplastic 3 Leukemia 3 Burkitt Lymphoma 3 Neoplasms, Plasma Cell 2 Myelodysplastic Syndromes 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Lymphohistiocytosis, Hemophagocytic 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Immunoblastic Lymphadenopathy 2 Hodgkin Disease 2 Epstein-Barr Virus Infections 2 Dendritic Cell Sarcoma, Interdigitating 2 Unspecified Childhood Solid Tumor, Protocol Specific 1 Sezary Syndrome 1 Sarcoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pneumonia, Pneumocystis 1 Pneumonia 1 Neuroma 1 Neuroectodermal Tumors, Primitive, Peripheral 1

Interventions

Ursodeoxycholic Acid 1 Steroids 1 Prednisone 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Liquid Biopsy 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡